Hasta ahora estos tratamientos sólo se podían realizar en ensayos clínicos que probaban su efectividad. Por último, y después de los buenos resultados, la Agencia Española del Medicamento y Prod...
Read moreIt has been presented the phase I/II clinical trial of the HSP-CAR30 treatment for patients with refractory or relapsed Hodgkin lymphoma and CD30+ T-cell lymphoma. This innovative cellular therapy, a ...
Read moreResearchers at IDIBAPS- Hospital Clínic have developed and validated a new CAR-T therapy called ARI0003 at a preclinical level. The new therapy combines two therapeutic targets to boost effectiveness...
Read moreBiotechnology has radically changed the treatment of many types of tumors, evolving from highly aggressive and non-specific treatments to those tailored to the unique characteristics of each patient. ...
Read moreCAR-T therapies have been effective in 60% of the pediatric patients who have received them; “we study why they have not worked in the rest,” explain CNIO researchers Cristina Aguirre and Andrés ...
Read moreEste tumor pediátrico poco frecuente tiene una alta tasa de recaída con los tratamientos convencionales. Según los autores del estudio publicado en Nature Medicine, se trata de la remisión más p...
Read moreIntegra Therapeutics has developed the FiCAT gene-writing platform to develop cell therapies for autoimmune and oncology diseases and gene therapies for rare diseases. The company recently announced a...
Read moreBased on alignment gained with FDA under the Regenerative Medicine Advanced Therapy (RMAT) designation, Neurona plans to conduct the Phase 3 EPIC (EPIlepsy Cell therapy) trial as the primary basis for...
Read moreThermo Fisher Scientific Inc, today announced the launch of the CorEvitas Systemic Lupus Erythematosus (SLE) Registry. The multi-center, prospective registry leverages the CorEvitas rheumatology physi...
Read moreAhora se da un paso más y a la administración de los fármacos se unirá también la producción de los mismos, convirtiéndose en breve la Arrixaca y la Sala Blanca IMIB-Pascual Parrilla en uno de ...
Read moreTreatment of B-cell Acute Lymphoblastic Leukaemia has improved thanks to CAR-T therapies, but relapse is still very common. An international team has now test in animal models a new "promising therape...
Read moreThe results show the need for continuous monitoring of patients to detect and manage possible adverse effects occurring months and years after treatment.
Read more